全文获取类型
收费全文 | 330篇 |
免费 | 22篇 |
国内免费 | 24篇 |
专业分类
儿科学 | 15篇 |
妇产科学 | 7篇 |
基础医学 | 43篇 |
口腔科学 | 3篇 |
临床医学 | 49篇 |
内科学 | 82篇 |
皮肤病学 | 2篇 |
神经病学 | 4篇 |
特种医学 | 54篇 |
外科学 | 39篇 |
综合类 | 7篇 |
预防医学 | 10篇 |
眼科学 | 2篇 |
药学 | 40篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 2篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 6篇 |
2017年 | 3篇 |
2016年 | 8篇 |
2015年 | 11篇 |
2014年 | 6篇 |
2013年 | 13篇 |
2012年 | 7篇 |
2011年 | 9篇 |
2010年 | 8篇 |
2009年 | 11篇 |
2008年 | 10篇 |
2007年 | 22篇 |
2006年 | 10篇 |
2005年 | 11篇 |
2004年 | 10篇 |
2003年 | 7篇 |
2002年 | 8篇 |
2001年 | 5篇 |
2000年 | 9篇 |
1999年 | 8篇 |
1998年 | 17篇 |
1997年 | 14篇 |
1996年 | 18篇 |
1995年 | 18篇 |
1994年 | 15篇 |
1993年 | 22篇 |
1992年 | 5篇 |
1991年 | 7篇 |
1990年 | 10篇 |
1989年 | 11篇 |
1988年 | 8篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 7篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1976年 | 2篇 |
1975年 | 1篇 |
排序方式: 共有376条查询结果,搜索用时 562 毫秒
121.
122.
B Shaharuddin SF Ismail-Mokhtar E Hussein 《国际眼科杂志》2007,7(5):1237-1239
目的:比较接受和不接受激素替代疗法的绝经后妇女干眼症的发生情况。方法:采用横断面研究方法比较对照组和接受激素替代疗法的绝经后妇女干眼症的发生。对所有的受试者行泪液分泌实验,泪膜破裂时间和玫瑰红孟加拉染色检查。结果:总共54例妇女被纳入研究,其中接受激素替代疗法(第2组)30例(55.6%),对照组24例(44.4%)没有进行任何激素治疗(第1组)。在第2组中,11例服用雌激素(2A组),其余19例同时服用雌激素和孕酮(2B组)。在第1组组中有29.2%发生了干眼症,第2组为70.0%(P=0.003),进一步分析发现2B组(84.2%)较2A组(45.5%)更多发生了干眼症(P=0.042)。结论:本研究发现在绝经后服用激素的妇女中干眼症比较常见,它否定了先前激素替代疗法具有防止干眼症发生的假设。 相似文献
123.
Background
Surveillance of Over-the-Counter pharmaceutical (OTC) sales as a potential early indicator of developing public health conditions, in particular in cases of interest to Bioterrorism, has been suggested in the literature. The data streams of interest are quite non-stationary and we address this problem from the viewpoint of linear adaptive filter theory: the clinical data is the primary channel which is to be estimated from the OTC data that form the reference channels. 相似文献124.
125.
Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation 总被引:8,自引:0,他引:8
Revanur VK Jardine AG Kingsmore DB Jaques BC Hamilton DH Jindal RM 《Clinical transplantation》2001,15(2):89-94
AIMS: To investigate the outcomes in patients who have pre-existing diabetes and those who develop post-transplant diabetes mellitus (PTDM). METHODS. We retrospectively reviewed the charts of 939 patients who received a first functioning renal transplant in the cyclosporine (CyA) era between 1984 and 1999. RESULTS. Sixty-six (7%) patients had renal failure due to insulin-dependent diabetes mellitus (IDDM) and 7 (0.8%) patients due to non-insulin-dependent diabetes mellitus (NIDDM). Ten (1.1%) patients had coexistent diabetes and 48 (5.1%) recipients developed PTDM. The mean graft survival for the patients with PTDM was 9.7 yr versus 11.3 yr for the non-diabetic patients, while mean graft survival was 10.1 yr for patients with IDDM and 2.9 yr with NIDDM and 8.3 yr for those with coexistent diabetes (p=ns). However, there was a statistically significant difference in patient survival between patients who developed PTDM and in those who did not develop this complication. The mean survivals of patients with IDDM, NIDDM, coexistent diabetics and PTDM were 8.4, 3.7, 8.6 and 10.3 yr, respectively. The mean survival of the patients without pre-existing diabetes or PTDM was 12.8 yr (p<0.001). The survival of patients older than 55 yr with PTDM was no different to the control group. However, in those younger than 55 yr, PTDM was associated with a higher risk of death (relative risk of 2.54, p<0.001). Fifty percent of patients with IDDM developed acute rejection episodes, whereas rejection rate was 57.1% in NIDDM group, 50.0% in the PTDM group, 20.0% in the coexistent diabetes group and 44.3% in the control group (p=ns). CONCLUSION. Patient survival, but not graft survival, was adversely affected by both pre-existing diabetes and by PTDM, particularly in those with an age less than 55 yr. 相似文献
126.
Kaukola T Herva R Perhomaa M Pääkkö E Kingsmore S Vainionpää L Hallman M 《Pediatric research》2006,59(3):478-483
Intrauterine inflammation may relate to neurologic disability among preterm children. We investigated the relationship between chorioamnionitis, cord serum cytokines, and neurologic outcome. Sixty-one consecutively born very preterm extremely low birth weight (ELBW) infants were prospectively enrolled. Histologic inflammation in placenta and umbilical cord and vascular pathology were evaluated. Cord sera were analyzed for five proinflammatory cytokines. Serial brain ultrasound and magnetic resonance imaging were performed for evaluation of intraventricular hemorrhage (IVH grade I-III) and white matter damage (WMD: cystic periventricular leukomalacia or IVH grade IV). Neurologic and neurocognitive outcomes were assessed at the corrected age of 2 y. The incidences of HCA, WMD, and abnormal neurologic outcome were 48%, 13% and 19%, respectively. HCA or high IL-6 in cord serum predicted spontaneous preterm labor with high accuracy. HCA increased the risk of IVH grade II-III. In HCA, without either clinical chorioamnionitis or histologic placental perfusion defect, the children had a low risk of WMD (0%) and a low risk of abnormal neurologic outcome (6%). In HCA, the concentration of IL-6 in cord serum was lower in children with abnormal neurologic outcome than in children with normal neurologic outcome. In HCA and placental perfusion defect (compound defect) the risk of abnormal neurologic outcome was high. Compound placental defect and WMD additively predicted abnormal neurologic outcome. We propose that HCA together with other insults (placental perfusion defect or maternal systemic infection) increases the risk of poor neurologic outcome in very preterm ELBW infants. 相似文献
127.
VJ Brooks TJ De Wolfe TJ Paulus J Xu J Cai NS Keuler RG Godbee SF Peek SM McGuirk BJ Darien 《African journal of traditional, complementary, and alternative medicines》2013,10(1):1-8
We have previously reported that Morinda citrifolia (noni) puree modulates neonatal calves developmental maturation of the innate and adaptive immune system. In this study, the effect of noni puree on respiratory and gastrointestinal (GI), health in preweaned dairy calves on a farm with endemic salmonellosis was examined. Two clinical trials were conducted whereby each trial evaluated one processing technique of noni puree. Trials 1 and 2 tested noni versions A and B, respectively. Puree analysis and trial methods were identical to each other, with the calf as the experimental unit. Calves were designated to 1 of 3 treatment groups in each trial and received either: 0, 15 or 30 mL every 12 hr of noni supplement for the first 3 weeks of life. Health scores, weaning age, weight gain from admission to weaning, and weaned by 6 weeks, were used as clinical endpoints for statistical analysis. In trial 1, calves supplemented with 15 mL noni puree of version A every 12 hr had a higher probability of being weaned by 6 weeks of age than control calves (P = 0.04). In trial 2, calves receiving 30 mL of version B every 12 hr had a 54.5% reduction in total medical treatments by 42 days of age when compared to controls (P = 0.02). There was a trend in reduced respiratory (61%), and GI (52%) medical treatments per calf when compared to controls (P = 0.06 and 0.08, respectively). There were no differences in weight gain or mortality for any treatment group in either trial. 相似文献
128.
129.
Nikita Raje Sarah Soden Douglas Swanson Christina E. Ciaccio Stephen F. Kingsmore Darrell L. Dinwiddie 《Current allergy and asthma reports》2014,14(10):1-13
Primary immunodeficiencies (PIDs) are a group of genetically heterogeneous disorders that present with very similar symptoms, complicating definitive diagnosis. More than 240 genes have hitherto been associated with PIDs, of which more than 30 have been identified in the last 3 years. Next generation sequencing (NGS) of genomes or exomes of informative families has played a central role in the discovery of novel PID genes. Furthermore, NGS has the potential to transform clinical molecular testing for established PIDs, allowing all PID differential diagnoses to be tested at once, leading to increased diagnostic yield, while decreasing both the time and cost of obtaining a molecular diagnosis. Given that treatment of PID varies by disease gene, early achievement of a molecular diagnosis is likely to enhance treatment decisions and improve patient outcomes. 相似文献
130.